Biomarkers in Prediction of AMI

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Acute Mesenteric Ischemia

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tartu University Hospital, Tartu, Estonia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 18 years or older
Initial decision in favour of further diagnostics of mesenteric ischaemia

Exclusion criteria

Age <18 years
Consent declined by patient or next of kin (delayed consent)
Chronic mesenteric ischaemia without an acute event
Immediate decision for withdrawal of further diagnostics and active treatment
Referral from another hospital with already established diagnosis of AMI
AMI diagnosed at surgery without previously having been considered

Treatment and study plan

Sequential blood samples

Diagnostic Test

Sequential blood samples for diagnostic tests is the only intervention in thei study

Primary outcomes

Rate of correctly predicted cases of acute mesenteric ischaemia

Time frame: 10 months

Rate of correctly predicted cases of Acute mesenteric ischaemia using different biomarkers

Study contacts

Contact information is provided by the study sponsor or research team.

Annika Reintam Blaser, PhD

CONTACT

[email protected]

+3725142281

Sponsors and collaborators

Lead sponsor

University of Tartu

Other

Registry information

Official study title

Biomarkers In Prediction of Acute Mesenteric Ischaemia: a Prospective Multicentre Study (BIPAMI Study)

Acronym: BIPAMI

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Jan 19, 2024
Registry last updated: Dec 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting